TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 8.3

Change

-0.01 (-0.12)%

Market Cap

N/A

Volume

3.03M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-25 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
TEM Tempus AI, Inc. Class A Common..

-0.60 (-1.12%)

USD 9.00B
HQY HealthEquity Inc

+0.04 (+0.05%)

USD 7.52B
WAY Waystar Holding Corp. Common S..

-0.26 (-0.70%)

USD 4.47B
BTSG BrightSpring Health Services, ..

+0.37 (+2.24%)

USD 3.00B
PRVA Privia Health Group Inc

-0.29 (-1.24%)

USD 2.92B
PINC Premier Inc

+0.11 (+0.53%)

USD 1.93B
SDGR Schrodinger Inc

+0.32 (+1.22%)

USD 1.79B
GDRX Goodrx Holdings Inc

-0.12 (-2.50%)

USD 1.73B
CERT Certara Inc

-0.25 (-1.73%)

USD 1.60B
OMCL Omnicell Inc

-0.25 (-0.80%)

USD 1.53B

ETFs Containing TXG

ESGO:PA AuAg ESG Gold Mining UCIT.. 4.28 % 0.00 %

-0.17 (-1.82%)

N/A
ESGO:LSE AuAg ESG Gold Mining UCIT.. 4.11 % 0.00 %

-0.19 (-1.82%)

USD 0.02B
FXM:CA First Asset Morningstar C.. 3.90 % 0.67 %

N/A

CAD 0.30B
GOEX Global X Gold Explorers E.. 3.28 % 0.65 %

-0.63 (-1.82%)

USD 0.06B
CGV Two Roads Shared Trust 2.12 % 0.00 %

-0.02 (-1.82%)

USD 0.10B
PZC:CA 0.00 % 0.67 %

N/A

N/A
XCS:CA iShares S&P/TSX Small Cap 0.00 % 0.61 %

-0.10 (-1.82%)

CAD 0.15B
ZGD:CA BMO Equal Weight Global G.. 0.00 % 0.61 %

-2.26 (-1.82%)

CAD 0.13B
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

-0.33 (-1.82%)

USD 0.12B
UBUD:XETRA UBS (Irl) ETF plc - Solac.. 0.00 % 0.00 %

-0.36 (-1.82%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -42.20% 17% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.20% 17% F 16% F
Trailing 12 Months  
Capital Gain -69.92% 15% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -69.92% 15% F 11% F
Trailing 5 Years  
Capital Gain -88.78% 32% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.78% 32% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -20.74% 31% F 13% F
Dividend Return -20.74% 31% F 13% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 57.74% 35% F 32% F
Risk Adjusted Return -35.92% 40% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector